[ Price : $8.95]
FDA says it will not meet the already-extended PDUFA action dates for Pfizer submissions for abrocitinib and Xeljanz.[ Price : $8.95]
FDA says it is soliciting applications for new Patient Engagement Collaborative members.[ Price : $8.95]
FDA grants full approval to the combination of Mercks Keytruda and Eisais Lenvima for treating certain patients with advanced endo...[ Price : $8.95]
An Annenberg Public Policy Center poll shows that the degree of confidence in FDA respondents have varies with their primary sourc...[ Price : $8.95]
CDRH director Jeff Shuren says two important lessons learned during the Covid-19 emergency that CDRH envisions continuing long aft...[ Price : $8.95]
An FDA Notice of Violation says The Regen Centers is marketing unapproved cellular products and exosomes.[ Price : $8.95]
The House Energy and Commerce Committee asks FDA acting commissioner Janet Woodcock what the agency intends to do about delayed dr...[ Price : $8.95]
FDA issues a finalized question-and-answer guidance on submitting field alert reports.